|
1
|
Lawrence RC, Felson DT, Helmick CG, Arnold
LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG,
et al: National Arthritis Data Workgroup: Estimates of the
prevalence of arthritis and other rheumatic conditions in the
United States: Part II. Arthritis Rheum. 58:26–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goldring MB and Goldring SR:
Osteoarthritis. J Cell Physiol. 213:626–634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xue J, Wang J, Liu Q and Luo A: Tumor
necrosis factor-α induces ADAMTS-4 expression in human
osteoarthritis chondrocytes. Mol Med Rep. 8:1755–1760.
2013.PubMed/NCBI
|
|
4
|
Matsukawa T, Sakai T, Yonezawa T, Hiraiwa
H, Hamada T, Nakashima M, Ono Y, Ishizuka S, Nakahara H, Lotz MK,
et al: MicroRNA-125b regulates the expression of aggrecanase-1
(ADAMTS-4) in human osteoarthritic chondrocytes. Arthritis Res
Ther. 15:R282013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Echtermeyer F, Bertrand J, Dreier R,
Meinecke I, Neugebauer K, Fuerst M, Lee YJ, Song YW, Herzog C,
Theilmeier G and Pap T: Syndecan-4 regulates ADAMTS-5 activation
and cartilage breakdown in osteoarthritis. Nat Med. 15:1072–1076.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song RH, Tortorella MD, Malfait AM, Alston
JT, Yang Z, Arner EC and Griggs DW: Aggrecan degradation in human
articular cartilage explants is mediated by both ADAMTS-4 and
ADAMTS-5. Arthritis Rheum. 56:575–585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barre PE, Redini F, Boumediene K, Vielpeau
C and Pujol JP: Semiquantitative reverse transcription-polymerase
chain reaction analysis of syndecan-1 and -4 messages in cartilage
and cultured chondrocytes from osteoarthritic joints.
Osteoarthritis Cartilage. 8:34–43. 2000. View Article : Google Scholar
|
|
8
|
Tkachenko E, Rhodes JM and Simons M:
Syndecans: New kids on the signaling block. Circ Res. 96:488–500.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Molténi A, Modrowski D, Hott M and Marie
PJ: Differential expression of fibroblast growth factor receptor-1,
-2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular
condyle and calvaria during osteogenic differentiation in vitro.
Bone. 24:337–347. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao G, Plaas A, Thompson VP, Jin S, Zuo F
and Sandy JD: ADAMTS4 (aggrecanase-1) activation on the cell
surface involves C-terminal cleavage by glycosylphosphatidyl
inositol-anchored membrane type 4-matrix metalloproteinase and
binding of the activated proteinase tochondroitin sulfate and
heparan sulfate on syndecan-1. J Biol Chem. 279:10042–10051. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dunn SL, Wilkinson JM, Crawford A, Le
Maitre CL and Bunning RA: Cannabinoid WIN-55,212-2 mesylate
inhibits interleukin-1β induced matrix metalloproteinase and tissue
inhibitor of matrix metalloproteinase expression in human
chondrocytes. Osteoarthritis Cartilage. 2:133–144. 2014. View Article : Google Scholar
|
|
12
|
Mbvundula EC, Bunning RA and Rainsford KD:
Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent
IL-1alpha-induced matrix degradation in bovine articular
chondrocytes in-vitro. J Pharm Pharmacol. 58:351–358. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dunn SL, Wilkinson JM, Crawford A and Le
Maitre CL: Novel therapies for arthritis? Future Med Chem.
4:713–725. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moncada-Pazos A, Obaya AJ, Viloria CG,
López-Otín C and Cal S: The nutraceutical flavonoid luteolin
inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities. J Mol Med
Berl. 89:611–619. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tauchi R, Imagama S, Natori T, Ohgomori T,
Muramoto A, Shinjo R, Matsuyama Y, Ishiguro N and Kadomatsu K: The
endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes
functional recovery after spinal cord injury. J Neuroinflammation.
9:532012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Doyle A and Griffiths JB: Cell and Tissue
Culture: Laboratory Procedures. Cell Quantification. John Wiley
& Sons, Inc; Chichester, England: pp. 58–59. 1998
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Pertwee RG, Howlett AC, Abood ME,
Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos
G, Mackie K, et al: International Union of Basic and Clinical
Pharmacology. LXXIX. Cannabinoid receptors and their ligands:
Beyond CB and CB1 and CB2. Pharmacol Rev.
62:588–631. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Y, Alexander SP, Kendall DA and
Bennett AJ: Cannabinoids and PPARalpha signalling. Biochem Soc
Trans. 34:1095–1097. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
O'Sullivan SE and Kendall DA: Cannabinoid
activation of peroxisome proliferator-activated receptors:
Potential for modulation of inflammatory disease. Immunobiology.
215:611–616. 2010. View Article : Google Scholar
|
|
21
|
Goldring MB and Marcu KB: Cartilage
homeostasis in health and rheumatic diseases. Arthritis Res Ther.
11:2242009. View
Article : Google Scholar : PubMed/NCBI
|
